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F ungal peritonitis, a relatively uncommon but serious complication of peritoneal dialysis (PD), is associated with high rates of technique failure (40%) and mortality (15%-50%). 1, 2 Therefore, immediate PD catheter removal followed by antifungal agent administration for a minimum period of 2 weeks is strongly recommended by the International Society for Peritoneal Dialysis 2016 peritonitis guideline. 3 Despite treatment according to this guideline, only one-third of patients with fungal peritonitis are able to resume PD. 4 The poor treatment outcomes of fungal peritonitis are hampered by the lack of a sensitive biomarker that can facilitate timely diagnosis and treatment. Serum levels of the fungal cell wall component galactomannan (GM), which is shed by fungi during their growth and death, 5 may help address this gap in clinical care. This biomarker has been used to aid in the diagnosis of systemic and invasive fungal infections, as well as in monitoring the treatment response and relapse of fungal infections, particularly of the respiratory system. 5 A serum GM index (GMI) of $0.5 has previously been used to diagnose suspected fungal pulmonary infections. 6, 7 As a proof of concept, the potential value of serum and PD effluent GMI in diagnosing and risk-stratifying patients with fungal peritonitis on PD was assessed in the present study.
RESULTS

Patient Demographics and Characteristics
Participant flow is shown in Figure 1 . There were no significant differences among patients with fungal peritonitis (n ¼ 23), bacterial peritonitis (n ¼ 21), and no peritonitis (n ¼ 19) with respect to age, sex, PD vintage, residual kidney function, and comorbidities (Table 1 , Supplementary Table S1 ). As expected, controls without peritonitis had no peritonitis symptoms, higher serum albumin concentrations, and lower PD effluent cell counts than did the other groups. The most common fungal pathogen was Candida spp. followed by Trichosporon spp., Aspergillus spp., and Fusarium spp. (Table 2) .
Serum GMI Values
Serum GMI in patients with fungal peritonitis was significantly higher than that in patients with bacterial peritonitis and controls without peritonitis (median, 0.85 [interquartile range, 0.43-1.75] vs 0.45 [interquartile range, 0.35-0.79] vs. 0.43 [interquartile range, 0.34-0.47], respectively; P ¼ 0.036) (Figure 2a ). To differentiate fungal peritonitis from non-fungal peritonitis (including bacterial peritonitis and nonperitonitis), a serum GMI cutoff value of $0.56
( Supplementary Table S2 ) provided the best diagnostic accuracy with 65.2% sensitivity, 85.0% specificity, 4.35 positive likelihood ratio, and 0.41 negative likelihood ratio. At this cutoff point, the calculated area under the curve from receiver operating characteristic curve analysis for serum GMI was 0.73 (95% confidence interval, 0.58-0.87) ( Table 3 and Figure 2b ).
Six patients with bacterial peritonitis (patients 2, 7, 13, 16, 19, and 20) had a positive GMI result. On the basis of polymerase chain reaction-based diagnosis of false-negative serum GMI results were the presence of a serum inhibitor or a lack of peripheral blood translocation in either the fungal whole cell or the cell wall. Of note, the follow-up serum titer of patient 29 increased to a level above the cutoff value at 1.88 during amphotericin B treatment.
DISCUSSION
Our case-cohort study demonstrated that serum GMI may be useful for the timely diagnosis of fungal peritonitis. Because GMI measurement is less timeconsuming than the conventional culture method (6 hours vs. 3-6 days), the more rapid diagnosis of fungal peritonitis by GMI offers a potential clinical advantage to patients on PD. The International Society for Peritoneal Dialysis 2016 peritonitis guideline recommended that an immediate catheter removal should be considered when fungi are identified in PD effluent. Earlier catheter removal is associated with improved outcomes, including mortality. 3 Optimal serum GMI cutoff values $0.5 have been used for the diagnosis of invasive fungal infections. 8,9,S1 However, in the present study, a slight increase in the cutoff to $0.56 provided the most optimal diagnostic accuracy for fungal peritonitis. This finding implies that there is a translocation of GM from the peritoneal fluid into the circulation in patients with fungal peritonitis. We demonstrated that serum GMI could be used for the diagnosis of fungal peritonitis with >65% sensitivity and 83% specificity. After excluding false positive from hemolytic serum (2 cases) and true positive from occult fungal infection (2 cases), there were 2 cases (10%) with bacterial peritonitis and false-positive serum GMI above the 0.56 cutoff. These cases involved specific bacterial pathogens known to produce false-positive GMI results, namely, Pseudomonas aeruginosa (1 case) and Escherichia coli (1 case). The false positivity in these cases possibly occurred because of (i) the high concentration of these organisms in the blood, causing a cross-reactivity in the Platelia Aspergillus enzyme immunoassay (Bio-Rad, Marnes-la-Coquette, France), 9 and (ii) transient fungal antigenemia from cow's milk products S2 or fungal overgrowth in the compromised gut during the episode of severe gram-negative peritonitis and prolonged antibiotic treatment. S3 Dietary factors must therefore be taken into account when interpreting the cause of false-positive results in young children and patients with an impaired intestinal barrier. In contrast, the false-negative GMI in 4 patients with Candida parapsilosis, Candida guilliermondii, Trichosporon spp., and Alternaria spp. might be related to fungal burden or the cell wall GM compositions of these fungi, leading to decreased sensitivity. GM detection is not possible in patients with Pneumocystis jiroveci, Candida spp. (some strains), and Acremonium spp. because of the absence of GM content in the cell walls of these fungi. S4 Meanwhile, the false-negative GMI occurred only in the serum of 4 patients who were infected with Aspergillus flavus, Exophiala spp., Exserohilum rostratum, and Fusarium solani. It is possible that fungal pathogens in all these cases did not invade into the bloodstream.
This study has some limitations. First, the number of patients in our proof-of-concept study was relatively small, such that a much larger study would be required to confidently establish the utility of serum GMI as a diagnostic biomarker for fungal peritonitis. Second, the results of this study may not generalize to populations on PD outside Thailand in whom the incidence of fungal peritonitis is appreciably lower.
In conclusion, serum GMI is a promising biomarker for the diagnosis of fungal peritonitis in patients on PD, particularly in conjunction with other parameters such as potassium hydroxide stain, culture, and polymerase chain reaction. 
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